Aug 3, 2021

Hahn-Schickard and Endress+Hauser establish "Endress+Hauser BioSense" joint venture

Food safety is one application area for the molecular analysis solutions that Endress+Hauser BioSense, a joint venture between Endress+Hauser and Hahn-Schickard, aims to develop in Freiburg, Germany.
Source: Endress+Hauser
Aug 3, 2021

Endress+Hauser BioSense GmbH develops methods for molecular analysis and greater safety in the food sector. Bacterial or viral contaminations in water and beverages, genetic changes in food, or the contamination of milk can thus be analyzed quickly.

Cooperation with the University of Freiburg

Hahn-Schickard has been working closely with the University of Freiburg for many years to develop rapid diagnostic methods that can detect even the smallest amounts of infectious pathogens on-site using mobile equipment. Last year, a rapid PCR test for SARS-CoV-2 was jointly launched. This technology is to be transferred from medical diagnostics to the application areas of industrial process and laboratory automation with the help of the new joint venture between Hahn-Schickard and Endress+Hauser.

Experienced management team

Endress+Hauser BioSense GmbH was founded in Freiburg, Germany, and will move next year to the Freiburg Innovation Center FRIZ, currently under construction on the campus of the Technical Faculty. Dr. Nicholas Krohn, Managing Director at Eurofins Genescan GmbH in Freiburg for many years and very familiar with the field of food analysis, has been recruited as Managing Director. The founding team is complemented by Dr. Stefan Burger and Dr. Martin Schulz, two long-standing and experienced Hahn-Schickard employees who have completed their doctorates in the field of molecular diagnostics at the Technical Faculty of the Albert Ludwig University in Freiburg.

Contact: Katrin Grötzinger, Hahn-Schickard
Katrin.Groetzinger@Hahn-Schickard.de

Member profile

Recommended articles

Apr 28, 2022

How can European and U.S. medical technology companies cooperate best to be competitive on the global market? The virtual workshop "Europe …

Apr 8, 2022

The international expert forum COMPAMED Innovation Forum will take place as a digital event on "Innovative Technologies for Neurological Applications" …

Jan 24, 2024

MD&M West in Anaheim stands out as one of the premier global platforms dedicated to showcasing advancements in medical technology …

Recommended events

Jun 3, 2024, 3:00 p.m. - 5:30 p.m.
Smart Implant Technology: Innovative Production and Future Applications
Nov 11 - 14, 2024
Product Market “High-tech for Medical Devices” and "COMPAMED HIGH-TECH FORUM" in Hall 8a, F29 (IVAM Lounge)
Feb 4 - 6, 2025
Medical Design & Manufacturing - IVAM presents Micro Nanotech Area in Hall C